Esperion Therapeutics, Inc. (ESPR)
2.17
+0.12
(+5.85%)
USD |
NASDAQ |
Apr 15, 16:00
2.18
+0.01
(+0.46%)
Pre-Market: 08:52
Esperion Therapeutics Accounts Payable (Quarterly) : 65.07M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Nektar Therapeutics | 10.77M |
| Harrow, Inc. | 35.36M |
| Corcept Therapeutics, Inc. | 40.44M |
| Catalyst Pharmaceuticals, Inc. | 11.20M |
| Regeneron Pharmaceuticals, Inc. | 939.00M |